Assertio investor relations material

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital and pain, and inflammation. The Company's neurology products are used to treat central nervous system disorders such as attention deficit hyperactivity disorder (ADHD), Parkinson's disease and epilepsy. Its hospital unit is involved in manufacturing injectable general solutions for parenteral nutrition applications. Its pain and inflammation business develops prescription topical creams that are used to treat various inflammatory joint-pain related symptoms.